Hepatitis C in a sample of pregnant women in Switzerland: Seroprevalence and sociodemographic factors

Swiss Medical Weekly

Volumn 137, Issue 1-2, 2007, Pages 27-32

  Prasad, L R ^a   Masserey Spicher, V ^b   Kammerlander C, R ^c   Zwahlen, Marcel ^a  

^a Department of Social and Preventive Medicine   (Switzerland)

^b FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

^c Service de Réadaptation Cardiovasculaire   (Switzerland)

Author keywords

Cross sectional study; Hepatitis C infection; Pregnant women; Screening; Switzerland

Indexed keywords

HEPATITIS B CORE ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN EXPERIMENT; PREGNANT WOMAN; PREVALENCE; SEROPREVALENCE; SOCIAL ASPECT; SWITZERLAND;

EID: 33846678280     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome. Science. 1989;244(4902):359-62.
2. WHO. Hepatitis C Fact Sheet No.164. Downloaded from http://www.who.int 2000; Accessed 16 Sept 2004.
3. Office Fédéral de la Santé Publique. Hépatite C en Suisse: Pour une information et un conseil individualisé. Bulletin de l'OFSP. 2001;46:877-81.
4. Broers B, Junet C, Bourquin M, Deglon JJ, Perrin L, Hirschel B. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. Aids. 1998;12(15):2059-66.
5. Steffen T, Blattler R, Gutzwiller F, Zwahlen M. HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme. Eur J Public Health. 2001;11(4):425-30.
6. Ambuhl PM, Binswanger U, Renner EL. Epidemiology of chronic hepatitis B and C among dialysis patients in Switzerland. Schweiz Med Wochenschr. 2000;130:341-8.
7. Niederhauser C, Schneider P, Fopp M, Ruefer A, Lévy G. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003. Euro Surveill. 2005;10(2):14-6.
8. Jacquier P, Hohlfeld P, Vorkauf H, Zuber P. Epidémiologie de la toxoplasmose en Suisse: étude nationale de séroprévalence menée chez les femmes enceintes en 1990-1991. Schweiz Med Wochenschr. 1995;125(Suppl. 65):29S-38S.
9. Bart P, Jacquier P, Zuber P, Lavanchy D, Frei P. Seroprevalence of HBV (anti-HBc, HbsAg and anti-HBs) and HDV infections among 9006 women at delivery. Liver 1996;16:110-6.
10. Jacquier P, Nadal D, Zuber P, Eckert J. Zur Lage der Infektion mit Toxoplasma gondii bei der schweizerischen Bevölkerung: Beitrag einer seroepidemiologischen Studie aus dem Kanton Zürich. Schweiz Med Wochenschr. 1995;125(Suppl.65):23S-28S.
11. Roberts EA, Yeung L. Maternal infant transmission of hepatitis C virus infection. Hepatology. 2002;36(5):Suppl.1:S106-S113.
12. Ward C. Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing. Gut. 2000;47:277-80.
13. Ades A, Parker S, Walker J, Cubitt W, Jones R. HCV prevalence in pregnant women in the UK. Epidemiol Infect. 2000;125:399-405.
14. Conte D. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15250 pregnant women. Hepatology. 2000;31(3):751-5.
15. Roudot-Thoraval F, Pawlotsky J-M, Deforges L, Girollet P-P, Dhumeaux D. Anti-HCV seroprevalence in pregnant women in France. Gut. 1993(Supplement):S55- S56.
16. Hutchinson S. Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation, and diagnosis. Gut. 2004;53:593-8.
17. Swiss Federal Office of Public Health. Infectious Diseases, Switzerland, 2003 http://www.bag.admin.ch/infreporting/gs03/e/index.htm (accessed 13 September 2005)
18. Dubois F, Desenclos J-C, Mariotte N, Goudeau A, and the collaborative study group. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution and risk factors. Hepatology. 1997;25:1490-6.
19. Couturier E, Brossard Y, Rotily M, Obadia Y, et al. Séropré valence des anticorps anti-V.H.C. dans un échantillon exhaustif de femmes ayant terminé une grossesse en régions Ile-de-France, Alpes-Côte-d'Azur. Bulletin Épidémiologique Hebdomadaire 1996;5:19-20.
20. Sagmeister M, Renner EL, Mullhaupt B, Wong JB. Simulation of hepatitis C based on a mandatory reporting system. Eur J Gastroenterol Hepatol. 2002;14:25-34.
21. WHO. Global surveillance and control of hepatitis C. Journal of Viral Hepatitis. 1999;6:35-47.
22. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology. 1999;30(4):1054-8.
23. Hupertz V. Perinatal hepatitis C infection. Ped Infect Dis. 2003;369-71.
24. Centers for Disease Control. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. 1998;16(RR-19).
25. Dienstag JL. Sexual and perinatal transmission of hepatitis C. Hepatology. 1997;26(3 Suppl.1):66S-70S.